These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38910781)

  • 1. Evaluation of the Role of C-reactive Protein as a Prognostic Indicator in Oral Pre-malignant and Malignant Lesions.
    Salema H; Joshi S; Pawar S; Nair VS; Deo VV; Sanghai MM
    Cureus; 2024 May; 16(5):e60812. PubMed ID: 38910781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Serum C-Reactive Protein Levels in Oral Premalignancies and Malignancies: A Comparative Study.
    Vankadara S; K P; Balmuri PK; G N; G VR
    J Dent (Tehran); 2018 Nov; 15(6):358-364. PubMed ID: 30842796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics.
    Reibel J
    Crit Rev Oral Biol Med; 2003; 14(1):47-62. PubMed ID: 12764019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study.
    Gosavi SR; Torkadi AA
    J Oral Maxillofac Pathol; 2020; 24(1):46-51. PubMed ID: 32508447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
    Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
    BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Significance of Serum C-Reactive Protein and Neutrophil-Lymphocyte Ratio in Predicting the Diagnostic Outcomes of Renal Mass Biopsy Procedure.
    Colakerol A; Sahin S; Yazar RO; Temiz MZ; Yuruk E; Kandirali E; Semercioz A; Muslumanoglu AY
    J Kidney Cancer VHL; 2023; 10(1):9-14. PubMed ID: 36793395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma.
    Grimm M; Lazariotou M
    Med Oncol; 2012 Sep; 29(3):1435-47. PubMed ID: 21853343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance.
    Chang CC; Sun CF; Pai HJ; Wang WK; Hsieh CC; Kuo LM; Wang CS
    Chang Gung Med J; 2010; 33(3):301-12. PubMed ID: 20584508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.
    Gockel I; Dirksen K; Messow CM; Junginger T
    World J Gastroenterol; 2006 Jun; 12(23):3746-50. PubMed ID: 16773693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy.
    Knittelfelder O; Delago D; Jakse G; Lukasiak K; Thurner EM; Thurnher D; Pichler M; Renner W; Stranzl-Lawatsch H; Langsenlehner T
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32182693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    G D; Nandan SRK; Kulkarni PG
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma.
    Metgud R; Bajaj S
    Biotech Histochem; 2016; 91(2):96-101. PubMed ID: 26529498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of spatula and cytobrush cytological techniques in early detection of oral malignant and premalignant lesions: a prospective and blinded study.
    Nanayakkara PG; Dissanayaka WL; Nanayakkara BG; Amaratunga EA; Tilakaratne WM
    J Oral Pathol Med; 2016 Apr; 45(4):268-74. PubMed ID: 26403502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Serum C-Reactive Protein Concentration and Nutritional Status of Malignant Tumor Patients.
    Yu JM; Yang M; Xu HX; Li W; Fu ZM; Lin Y; Shi YY; Song CH; Shi HP; Guo ZQ;
    Nutr Cancer; 2019; 71(2):240-245. PubMed ID: 30450976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of Early Detection of Potentially Malignant Lesions in the Prevention of Oral Cancer.
    Hadzic S; Gojkov-Vukelic M; Pasic E; Dervisevic A
    Mater Sociomed; 2017 Jun; 29(2):129-133. PubMed ID: 28883777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
    Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
    Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer.
    Nozoe T; Iguchi T; Adachi E; Matsukuma A; Ezaki T
    Surg Today; 2011 Apr; 41(4):510-3. PubMed ID: 21431483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the combination of pre- and postoperative C-reactive protein in colorectal cancer patients.
    Yamamoto M; Saito H; Uejima C; Tanio A; Takaya S; Sakamoto T; Honjo S; Maeta Y; Ashida K; Fujiwara Y
    Surg Today; 2018 Nov; 48(11):986-993. PubMed ID: 29946884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions.
    Park DS; Kim D; Hwang KE; Hwang YR; Park C; Seol CH; Cho KH; Kim BR; Park SH; Jeong ET; Kim HR
    Yonsei Med J; 2013 Mar; 54(2):396-402. PubMed ID: 23364973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.